<--- Back to Details
First PageDocument Content
Science / Design of experiments / Pharmacology / HIV/AIDS / Evaluation methods / Zidovudine / Placebo-controlled study / Antiretroviral drug / Clinical trial / Medicine / Health / Clinical research
Date: 2014-05-29 11:30:01
Science
Design of experiments
Pharmacology
HIV/AIDS
Evaluation methods
Zidovudine
Placebo-controlled study
Antiretroviral drug
Clinical trial
Medicine
Health
Clinical research

Unexpected Deaths in Panama

Add to Reading List

Source URL: www.cdc.gov

Download Document from Source Website

File Size: 434,89 KB

Share Document on Facebook

Similar Documents

Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero Cataland, Flora Peyvandi, Paul Coppo,

DocID: 1utac - View Document

Clin Exp Allergy 2002; 32:928±932 A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects M. Semizzi, G. Senna*, M. Crivellaro*, G. Rapacioli{, G. Passalacqua{,

DocID: 1t7cl - View Document

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemothe

DocID: 1rDJY - View Document

Medicine / Alternative medicine / Pseudoscience / Health / Consumer fraud / Homeopathy / Placebo-controlled study / Sinusitis

Press release from the International Council for Homeopathy ICH is the international professional platform representing the interests of 32 national associations of professional homeopathy practitioners in 30 Countries

DocID: 1qj7u - View Document

Alcohols / Prostaglandins / Acetic acids / Treprostinil / Carboxylic acids / Orphan drugs / Pulmonary hypertension / Prostacyclin / Bosentan

TRIUMPH I study: Double Blind Placebo Controlled Clinical Investigation into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients with Severe Pulmonary Arterial Hypertension

DocID: 1oueC - View Document